In vitro vaccine challenge of PBMCs from BNT162b2 anaphylaxis patients reveal HSP90alpha-NOD2-NLRP3 nexus. Ko HL, Zhuo N, Chang ZW, Santosa A, et al. Allergy 2022 Sep 3. doi: 10.1111/all.15503.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ko HL, Zhuo N, Chang ZW, Santosa A, et al. In vitro vaccine challenge of PBMCs from BNT162b2 anaphylaxis patients reveal HSP90alpha-NOD2-NLRP3 nexus. Allergy 2022 Sep 3. doi: 10.1111/all.15503.
PMID: 36056775